1. Ding, Fei, Qiu, Chunping, Li, Wenzhi, Ma, Xiaohong, Jiang, Jie. 2021. CNR1 may reverse progesterone-resistance of endometrial cancer through the ERK pathway. In Biochemical and biophysical research communications, 548, 148-154. doi:10.1016/j.bbrc.2021.02.038. https://pubmed.ncbi.nlm.nih.gov/33640608/
2. D'Addario, Claudio, Pucci, Mariangela. . DNA Methylation Analysis of Cnr1 Gene Promoter. In Methods in molecular biology (Clifton, N.J.), 2576, 373-384. doi:10.1007/978-1-0716-2728-0_31. https://pubmed.ncbi.nlm.nih.gov/36152203/
3. Gouvêa, Eduardo S, Santos, Airton F, Ota, Vanessa K, Cordeiro, Quirino, Belangero, Sintia I. 2017. The role of the CNR1 gene in schizophrenia: a systematic review including unpublished data. In Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999), 39, 160-171. doi:10.1590/1516-4446-2016-1969. https://pubmed.ncbi.nlm.nih.gov/28099629/
4. Palmer, Rohan H C, McGeary, John E, Knopik, Valerie S, Bidwell, L Cinnamon, Metrik, Jane M. 2019. CNR1 and FAAH variation and affective states induced by marijuana smoking. In The American journal of drug and alcohol abuse, 45, 514-526. doi:10.1080/00952990.2019.1614596. https://pubmed.ncbi.nlm.nih.gov/31184938/
5. Tao, Ran, Li, Chao, Jaffe, Andrew E, Hyde, Thomas M, Kleinman, Joel E. 2020. Cannabinoid receptor CNR1 expression and DNA methylation in human prefrontal cortex, hippocampus and caudate in brain development and schizophrenia. In Translational psychiatry, 10, 158. doi:10.1038/s41398-020-0832-8. https://pubmed.ncbi.nlm.nih.gov/32433545/
智鼠故事 
